Results 261 to 270 of about 24,309,158 (381)
ABSTRACT There is a limited understanding of how pulmonary hypertension (PH) patients are managed worldwide. The Pulmonary Vascular Research Institute (PVRI) Innovative Drug Discovery Initiative (IDDI) global survey attempted to obtain insights into access to PH care in diverse international regions to pave future action plans.
Sasha Z. Prisco +9 more
wiley +1 more source
Prognostic Value of Plasma Big Endothelin-1 in Patients Hospitalized for Heart Failure. [PDF]
Wang J +9 more
europepmc +1 more source
ABSTRACT Pulmonary Langerhans cell histiocytosis (PLCH) frequently complicated by pulmonary hypertension (PH), which markedly worsens prognosis. We retrospectively reviewed three institutional PLCH‐PH cases treated with off‐label Sotatercept added to background triple therapy and performed a systematic review of published PLCH‐PH reports (PubMed/Embase
Giorgi Chilingarashvili +7 more
wiley +1 more source
Subclinical myocardial dysfunction in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus: Associations with Endothelin-1, E-selectin, and Endocan. [PDF]
Çulcuoğlu İ +7 more
europepmc +1 more source
ABSTRACT Exercise testing has long been essential for evaluating diagnosis, prognosis, and functional status in pulmonary hypertension (PH). Recent advances have clarified its role in defining reference values and prognostic markers. Nonetheless, substantial knowledge gaps persist regarding the implementation of invasive cardiopulmonary exercise ...
Aaron B. Waxman +20 more
wiley +1 more source
Serum big endothelin-1 is a significant biomarker of arterial stiffness in patients undergoing coronary artery bypass grafting. [PDF]
Jhan JY +4 more
europepmc +1 more source
Carlene D. Moore +13 more
semanticscholar +1 more source
Subcutaneous Treprostinil in PH Associated With Left Heart Disease or Chronic Lung Disease
ABSTRACT Pulmonary hypertension (PH) associated with left heart disease (LHD‐PH) and pulmonary hypertension associated with chronic lung disease (CLD‐PH) are the most common PH subtypes but lack effective treatments. In a prospective cohort study, 90 patients (39 LHD‐PH, 51 CLD‐PH) with severe disease [pulmonary vascular resistance (PVR) > 5 Wood units
Roela Sadushi‐Koliçi +8 more
wiley +1 more source

